5, 6 - COVID-19 pandemic
6 - new COVID variants
7, 8 - prioritization of testing supplies
9 - slowing disease spread
10, 11 - mismatched latent and incubation periods
12, 13, 14, 15 - undetected totally asymptomatic spreaders
16, 17 - testing, contact tracing, and quarantine control strategies
18 - limited resource constraints
19 - vaccination control
20, 21 - masking and social distancing
22, 23, 24, 25, 26, 27, 28, 29
N total susceptible, exposed, infectious, and recovered individuals
fA and fY
EA(t) = ∞ 0 dx eA(t, x)
eA(t, x)dx
eY (t, x)
3 - fraction κ of the non-symptomatic population XN (t)
6 - Clinical testing rate is given by 1/τC
7 - κ ∈ (0, 1]
8 - η ∈ [0, 1)
9 - η = 0.95
10 - τ−1 C = (cid:105)−1 (cid:104)
None
C: Testing capacity - Maximum number of tests able to be administered and processed per day per capita
τ: Testing time - Average amount of time required for an individual be tested (including procrastination, travel time, processing time, etc.) absent of back- logs or delays due to other patients
ρ: Strategy parameter - Fraction of tests allocated to clinical testing
None
32, 33, 34, 35, 36, 37
10
11
38
39
40
30
31
41
12: βλY βλA , Run + (1 − fA) 0 = fA r r
15: fA = 0.75 and fY = 0.25
16: βλY βλA , Run + (1 − fA) 0 = fA r r
45, 46, 47: Run 0 = 3.0
11, 48, 49: Run 0 = 6.4
49, 50: Run 0 = 9.5
(cid:104)fε(cid:105) = 5.48, σε = 2.72
(cid:104)fε(cid:105) = 5.48, σε = 5.48
(cid:104)fr(cid:105) = 16.38, σr = 2.02
(cid:104)fr(cid:105) = 16.38, σr = 2.02
(cid:104)finf(cid:105) = 10.92, σinf = 3.34
(cid:104)finf(cid:105) = 11.26, σinf = 4.81
(cid:104)ftot(cid:105) = 16.40, σtot = 2.02
(cid:104)ftot(cid:105) = 16.74, σtot = 2.69
(c
30, Refs. (30, 31, 11, 41)
31, Refs. (30, 31, 11, 41)
11, Refs. (30, 31, 11, 41)
41, Refs. (30, 31, 11, 41)
2, Table 2
4, Table 4
18, medRxiv preprint doi: https://doi.org/10.1101/2022.11.06.22281984
51, (51, 52, 28)
52, (51, 52, 28)
28, (51, 52, 28), (28, 29)
29, (28, 29)
5, Table 5
Run 0 = 3.0, 6.4, and 9.5 
(cid:104)fε(cid:105) = 5.48, 4.00, and 1.50 days
8a
8b
9
10
None
10: Figs. 10 
12: Figs. 12 
13: Fig. 13 
2: Tables 2 
3: Tables 3 
4: Tables 4 
6: Tables 6 
None
39 - medRxiv preprint doi: https://doi.org/10.1101/2022.11.06.22281984 
None
27 - quarantining is more effective under the exponential assumption
3 - ODE model can severely overestimate controllability
4.2 - Influence of model assumptions on controllability
z - incubation-latent offset
None
2003 SARS
COVID-19
11 Min Kang, Hualei Xin, Jun Yuan, Sheikh Taslim Ali, Zimian Liang, Jiayi Zhang, Ting Hu, Eric HY Lau, Yingtao Zhang, Meng Zhang, Benjamin J Cowling, Yan Li, and Peng Wu. Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta vari- ant infections in Guangdong, China, May to June 2021. Eurosurveillance, 27, 2022. doi: 10.2807/1560-7917.ES.2022.27.10.2100815.
12 Nathan W. Furukawa, John T. Brooks, and Jeremy Sobel. Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic. Emerg Infect Dis, 26:e201595, 2020. doi: 10.3201/eid2607.201595.
45 medRxiv preprint doi: https://doi.org/10.1101/2022.11.06.22281984 ; this version posted November 7, 2022. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who
[21] Kristina P. Vatcheva, Josef Sifuentes, Tamer Oraby, Jose Campo Maldonado, Timothy Huber, and Mara Cristina Villalobos. Social distancing and testing as optimal strategies against the spread of COVID-19 in the Rio Grande Valley of Texas. Infect Dis Model, 6:729–742, 2021. doi: 10.1016/j.idm.2021.04.004.
[22] Calistus N. Ngonghala, Enahoro A. Iboi, and Abba B. Gumel. Could masks curtail the post- lockdown resurgence of COVID-19 in the US? Mathl Biosci, 329:108452, 2020. doi: 10.1016/ j.mbs.2020.108452.
[23] Colin J. Worby and Hsiao-Han Chang. Face mask use in the general population and optimal resource allocation during the COVID-19 pandemic. Nat Commun, 11:4049, 2020. doi: 10. 1038/s41467-020-17922-x.
[24] Sarah F. Poole, Jessica Gronsbell,
[32] Jantien A Backer, Don Klinkenberg, and Jacco Wallinga. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 2028 January 2020. Eurosurveillance, 25, 2020. doi: 10.2807/1560-7917.ES.2020.25.5.2000062.
[33] Stephen A. Lauer, Kyra H. Grantz, Qifang Bi, Forrest K. Jones, Qulu Zheng, Hannah R. Meredith, Andrew S. Azman, Nicholas G. Reich, and Justin Lessler. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported conﬁrmed cases: Estimation and application. Ann Intern Med, 172:577–582, 2020. doi: 10.7326/M20-0504.
[34] Qun Li, Xuhua Guan, Peng Wu, Xiaoye Wang, Lei Zhou, Yeqing Tong, Ruiqi Ren, Kathy S.M. Leung, Eric H.Y. Lau, Jessica Y. Wong, Xuesen X
[41] Mina Park, Colleen Pawliuk, Tribesty Nguyen, Amanda Griﬃtt, Linda Dix-Cooper, Nadia Fourik, and Martin Dawes. 
[42] Yang Liu, Li-Meng Yan, Lagen Wan, Tian-Xin Xiang, Aiping Le, Jia-Ming Liu, Malik Peiris, Leo L M Poon, and Wei Zhang. 
[43] A. Maisa, G. Spaccaferri, L. Fournier, J. Schaeﬀer, J. Deniau, P. Rolland, B. Coignard, A. Andrieu, O. Broustal, S. Chene, S. Chent, E. Fougre, G. Gbaguidi, M. Hamidouche, A. Lamy, Q. Mano, B. Mastrovito, A. Mercier, G. Modenesi, G. Picard, J. Prudhomme, F. Rapilly, A. Riondel, M. Rivire, B. Villegas Ramirez, A. Zhu-Soubise, M. Zurbaran
[46] Ral Patricio Fernndez-Naranjo, Eduardo Vsconez-Gonzlez, Katherine Simbaa-Rivera, Lenin Gmez-Barreno, Juan S. Izquierdo-Condoy, Domnica Cevallos-Robalino, and Esteban Ortiz- Prado. Statistical data driven approach of COVID-19 in Ecuador: R0 and Rt estimation via new method. Infect Dis Model, 6:232–243, 2021. doi: 10.1016/j.idm.2020.12.012.
[47] Cheng-Jun Yu, Zi-Xiao Wang, Yue Xu, Ming-Xia Hu, Kai Chen, and Gang Qin. Assessment of basic reproductive number for COVID-19 at global level: A meta-analysis. Medicine, 100: e25837, 2021. doi: 10.1097/MD.0000000000025837.
[48] Ying Liu and Joacim Rocklv. The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus. J Travel Med, 28:taab124,
